Belvedere Trading
OYST

Belvedere Trading’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Belvedere Trading’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,900
Closed -$207K – 710
2021
Q3 		$207K Buy
+14,900
New +$217K 0.01% 244

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Belvedere Trading's OYST Position: Q4 2021 in Review

Belvedere Trading sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2021, closing a stake of 9,047 shares — an estimated $125K sold.

Belvedere Trading first reported a position in OYST in Q3 2021 and held it in 1 quarter. The position peaked at $125K in Q3 2021. 80 funds tracked by Wall St. Rank hold OYST as of Q4 2021.

  • Belvedere Trading reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Belvedere Trading sold 9,047 Oyster Point Pharma, Inc. Common Stock shares in Q4 2021, an estimated $125K.
  • Belvedere Trading first reported a position in Oyster Point Pharma, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Belvedere Trading's Oyster Point Pharma, Inc. Common Stock position peaked at $125K in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2021.

Based on Belvedere Trading's 13F filing for Q4 2021, filed 25 Jan 2022.